Request Sample Inquiry
Cannabidiol (CBD) Market

Cannabidiol (CBD) Market

Cannabidiol (CBD) Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:


Base Year:



Jan - 2022



Report Code:


Segments Covered
  • By Source Hemp, Marijuana
  • By Distribution Channel Online, Offline
  • By End-Use Medical, Personal Use, Pharmaceuticals, Wellness
  • By Region North America, Latin America, Europe, Asia Pacific, Middle East & Africa
Forecast YearsForecast Years: 2022 - 2028
Historical YearsHistorical Years: 2016 - 2021
Revenue 2021Revenue 2021: USD 4.9 Billion
Revenue 2028Revenue 2028: USD 47.22 Billion
Revenue CAGRRevenue CAGR (2022 - 2028): 21.3%
Fastest Growing Region Fastest Growing Region (2022 - 2028) Asia Pacific
Largest Region Largest Region (2021): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report
  • Go To Market Strategy
  • Region Specific Market Dynamics
  • Region Level Market Share
  • Import Export Analysis
  • Production Analysis
  • Others Request Customization Speak To Analyst
Cannabidiol (CBD)  Market Share

Market Synopsis:

Global Cannabidiol (CBD) Market is valued at USD 4.9 Billion in 2021 and is projected to attain a value of USD 47.22 Billion by 2028 at a CAGR of 21.3% during the forecast period, 2022–2028. The demand for Cannabidiol (CBD) for health and wellness purposes is strong due to its therapeutic characteristics, which is a major factor driving market growth. Furthermore, increased product acceptance and use as a result of regulatory approvals is likely to promote Cannabidiol (CBD) -infused product production. Cannabidiol (CBD) is the most extensively used Cannabidiol (CBD) for therapeutic purposes due to its absence of psychoactive effects. Cannabidiol (CBD) oil is utilised in a variety of medical applications, including anxiety and depression treatment, stress reduction, diabetes prevention, pain relief, cancer symptom relief, and inflammation relief. The global Cannabidiol (CBD) market is expected to develop at a lucrative rate over the forecast period, owing to the increased acceptance of Cannabidiol (CBD) -based products to treat diseases.

Cannabidiol (CBD) Market Size, 2021 To 2028 (USD Billion)

COVID-19's increased prevalence is expected to have an impact on market growth over the projection period. The COVID-19 dilemma has had a significant and immediate impact on the healthcare industry. Because of the unexpected impact on the supply chain and the limits imposed on manufacturing and supply operations during the early stages of the coronavirus pandemic, most companies suffered a minor loss in the first few quarters. COVID-19, on the other hand, has raised demand for therapeutics, especially Cannabidiol (CBD) , and some important players have seen favourable sales growth as a result of the increased demand.

Large Scale Adoption of Cannabidiol Products as Alternative to Conventional Medicine

Due to the rising prevalence of cancer, an increasing number of individuals are undergoing chemotherapy and experiencing nausea. Muscle disorders have also increased in recent years as a result of countless people around the world adopting a sedentary lifestyle. Cannabidiol (CBD) medications have been shown to be useful against symptoms, and they are becoming increasingly popular among patients. Furthermore, Cannabidiol (CBD) products are subjected to several scientific trials involving the treatment of a variety of illnesses, including neuropathic pain, among others. As a result, while conventional medicine exists to treat such disorders, worries about its adverse effects have paved the door for Cannabidiol (CBD) products to enter the market. Furthermore, regulatory agencies such as the FDA have given it commercial approval due to its shown therapeutic effects.

Limited Approval from the Authorities

Despite the fact that the legal structure is known to promote market demand, various loopholes limit the Cannabidiol (CBD) market's potential growth across sectors. For example, while Cannabidiol (CBD) products are approved for medical and cosmetic use across the globe, regulatory authorities have resisted Cannabidiol (CBD) acceptance as a food and beverage additive. While some states, like as Texas, allow the consumption of hemp-derived Cannabidiol (CBD) -infused foods and beverages, federal authorization is limited, causing bottlenecks in the supply chain.

Market Segmentation:

The Global Cannabidiol (CBD) Market can be segmented by Source Type, into Hemp and Marijuana. Based on Distribution Channel, Online and Offline. Based on End-Use, Medical, Personal Use, Pharmaceuticals and Wellness. Based on Region, the Market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Below tree is interactive. You can click the nodes to get more information.

North America to Continue Dominating the Cannabidiol (CBD) Market

North America dominated the market in 2020 and will continue to do so in the future. Some of the primary causes fuelling the region's growth include the existence of a significant population of health-conscious individuals, increased adoption of -based products, the presence of big manufacturers, and the passage of the United States Farm Bill in 2020. North America is widely regarded as the most progressive region in terms of and its derivatives, such as . It boasts the most CBD firms and the most permissive rules regulating the use of CBD products.

Key Players:

Some of the players are Aurora Cannabis, Canopy Growth Corporation, Cronos Group, CV Sciences, Inc., Medterra, and Tilray.

Cannabidiol (CBD) Market is segmented as follows:

Parameter Details
Segments Covered
  • Source (Hemp, Marijuana)
  • Distribution Channel (Online, Offline)
  • End-Use (Medical, Personal Use, Pharmaceuticals, Wellness)
  • Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
Regions & Countries Covered
  • North America - (U.S., Canada, Mexico)
  • Europe - (U.K., France, Germany, Italy, Spain, Rest Of Europe)
  • Asia Pacific - (China, Japan, India, South Korea, South East Asia, Rest Of Asia Pacific)
  • Latin America - (Brazil, Argentina, Rest Of Latin America)
  • Middle East & Africa - (GCC Countries, South Africa, Rest Of Middle East & Africa)
Companies Covered
  • Aurora Cannabis
  • Canopy Growth Corporation
  • Cronos Group
  • CV Sciences Inc.
  • Medterra
  • and Tilray
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis

Cannabidiol (CBD) Market is tabulated as follows:

Cannabidiol (CBD) Market Projected to Reach Valuation of USD 47.22 Billion by 2028
In terms of revenue, the Global Cannabidiol (CBD) market is expected to reach USD 47.22 Billion by 2028, growing at a Compound Annual Growth Rate (CAGR) of 21.3% from 2022 to 2028. The healing properties in Cannabidiol (CBD) for health and wellness purposes is high, which is a primary factor that ...
Frequently Asked Question
  • The global Cannabidiol (CBD) valued at USD 4.9 Billion in 2020 and is expected to reach USD 47.22 Billion in 2028 growing at a CAGR of 21.3%.

  • The prominent players in the market are Aurora Cannabis, Canopy Growth Corporation, Cronos Group, CV Sciences, Inc., Medterra, and Tilray.

  • The market is project to grow at a CAGR of 21.3% between 2021 and 2028.

  • The driving factors of the Cannabidiol (CBD) include

    • Large Scale Adoption of Cannabidiol Products as Alternative to Conventional Medicine

  • North America was the leading regional segment of the Cannabidiol (CBD) in 2020.